KCI등재
학술저널
동물세포배양기술을 이용한 유전자재조합의약품 산업 현황과 발전 방안
A Strategy for Improvement of Recombinant Pharmaceutical Industry Using Animal Cell Culture Technology
- 방규호(Kyu Ho Bang) 김경수(Kyeong Soo Kim)
- 대한약학회
- 약학회지
- 제65권 제1호(2021년)
- 등재여부 : KCI등재
- 2021.02
- 1 - 9 (9 pages)
This study was undertaken to suggest a strategy for improving the recombinant pharmaceutical industry using animal cell culture technology. The status of markets and policies of domestic and global biosimilar recombinant products and the media industry were investigated. Based on this investigation, we suggest seven ideas for improving technical development and the licensing, production, and market launch phases as a strategy for improving the recombinant pharmaceutical industry using animal cell culture technology.
서 론(Introduction)
방 법(Methods)
결 과(Results)
고 찰(Discussion)
결 론(Conclusion)
감사의 말씀(Acknowledgment)
Conflict of Interest
References